CA2202173A1 - Utilisation d'inhibiteurs de la cyclo-oxygenase dans le traitement de maladies neurodegeneratives - Google Patents

Utilisation d'inhibiteurs de la cyclo-oxygenase dans le traitement de maladies neurodegeneratives

Info

Publication number
CA2202173A1
CA2202173A1 CA 2202173 CA2202173A CA2202173A1 CA 2202173 A1 CA2202173 A1 CA 2202173A1 CA 2202173 CA2202173 CA 2202173 CA 2202173 A CA2202173 A CA 2202173A CA 2202173 A1 CA2202173 A1 CA 2202173A1
Authority
CA
Canada
Prior art keywords
cox
phenyl
agents
treatment
cyclooxygenase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2202173
Other languages
English (en)
Inventor
Raymond George Hill
Dalip Jaicaran Sastri Sirinathsinghji
Yves Ducharme
Jacques Yves Gauthier
Yves Leblanc
Serge Leger
Petpiboon Prasit
Michel Therien
Zhaoyin Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Organon Pharma UK Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9420616A external-priority patent/GB9420616D0/en
Application filed by Individual filed Critical Individual
Publication of CA2202173A1 publication Critical patent/CA2202173A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un procédé de traitement de troubles neurodégénératifs tels que la maladie d'Alzheimer, dans lequel on utilise un inhibiteur de COX-2.
CA 2202173 1994-10-12 1995-10-09 Utilisation d'inhibiteurs de la cyclo-oxygenase dans le traitement de maladies neurodegeneratives Abandoned CA2202173A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9420616.6 1994-10-12
GB9420616A GB9420616D0 (en) 1994-10-12 1994-10-12 Method, compositions and use
PCT/GB1995/002382 WO1996011676A1 (fr) 1994-10-12 1995-10-09 Utilisation d'inhibiteurs de la cyclo-oxygenase dans le traitement de maladies neurodegeneratives

Publications (1)

Publication Number Publication Date
CA2202173A1 true CA2202173A1 (fr) 1996-04-25

Family

ID=29404341

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2202173 Abandoned CA2202173A1 (fr) 1994-10-12 1995-10-09 Utilisation d'inhibiteurs de la cyclo-oxygenase dans le traitement de maladies neurodegeneratives

Country Status (1)

Country Link
CA (1) CA2202173A1 (fr)

Similar Documents

Publication Publication Date Title
KR100215358B1 (ko) 사이클로 옥시게나 제-2 억제제로서의 페닐헤테로사이클
US6329421B1 (en) Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
DE69406903T2 (de) 3,4-diarylthiophene und analoga davon, sowie deren verwendung als entzündungshemmende mittel
US5840746A (en) Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
BG100350A (bg) Фенилови хетероциклени съединения като инхибиторина циклооксигеназа-2
WO2004045509A2 (fr) Methode de therapie combinee utilisant un inhibiteur de cox-2 et un modulateur du recepteur 5-ht1a
WO2002100846A1 (fr) Composes et methodes de traitement ou de prevention d'infections a flavivirus
ZA200110349B (en) Combination of tumors necrocis factor (TNF) antagonists and cox-2 inhibitors for the treatment of inflammation.
CN1774428B (zh) M期驱动蛋白抑制剂
WO1996011676A1 (fr) Utilisation d'inhibiteurs de la cyclo-oxygenase dans le traitement de maladies neurodegeneratives
AU2002331076A2 (en) Compositions for the treatment and prevention of pain and inflammation with cyclooxygenase-2 selective inhibitor and glucosamine
MXPA04011690A (es) Moduladores de receptor x de higado de sulfona.
JP2007520483A (ja) シクロオキシゲナーゼ−２インヒビターとしてのジアリール−２−（５ｈ）−フラノンの一酸化窒素放出プロドラッグ
WO2003090869A1 (fr) Modulateurs de lxr
WO2005020926A2 (fr) Traitement ou prevention de troubles vasculaires au moyen d'inhibiteurs de cox-2 associee a des inhibiteurs de la phosphodiesterase specifique de l'amp cyclique
KR20050119648A (ko) 이미노 에테르 유도체 화합물 및 그 화합물을 유효성분으로서 함유하는 약제
AU2003207453A2 (en) Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
EP0853481A1 (fr) Compositions de traitement d'inflammations contenant certaines prostaglandines et un inhibiteur de cyclo-oxygenase-2 selectif
CA2202173A1 (fr) Utilisation d'inhibiteurs de la cyclo-oxygenase dans le traitement de maladies neurodegeneratives
AU715676B2 (en) Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
RU2349587C2 (ru) Производное фенилуксусной кислоты и его применение
JPH0583551B2 (fr)
EP1505985A1 (fr) Therapie de combinaison destinee a traiter des maladies a mediation par cyclooxygenase-2 chez des malades presentant un risque d'accident cardiovasculaire thrombotique
AU764875B2 (en) Combination of a GABA-A alpha 5 inverse agonist and COX-2 inhibitor, NSAID, estrogen or vitamin
AU2774602A (en) Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead